Pharma stocks: January gains

Pharma stocks: January gains

The virus situation seems to be improving. The UK passed the peak of infections, the US and Europe see improvements, too. Vaccines are being distributed all over the world. Not without obstacles but still, the process is unrolling. In this regard, it makes sense to look at the pharma stocks that all surged in 2020 on the pandemic.

Let’s put it like this: if you entered a position at the end of 2020, what would your profit be now?

Novavax is no doubt a champion here. It was floating above the support of $108 just a couple of weeks ago. Currently, it trades at $285 – that’s just slightly less than a 300% growth. All that is thanks to the vaccine production that appears to have taken a steady course and is expected to deliver the shots by summer.

Inovio made a slower rise but as spectacular. Starting at around $9 per share in the middle of January, it came to $19 right this week, ceding back below $15 however.

Moderna, the pharma company that was second after Pfizer in the race for vaccine delivery, dropped to $104 as the year began. However, since then, it gained more than 80% of value rising to $185 per share.

Emergent BioSolutions rose from $90 to $118 through the last several weeks taking #4 in the league of the pharma stocks.

All these stocks are at the forefront of the pharma industry now, and they will enjoy high demand through 2021 as even Pfizer CEO said that Covid-19 is “here to stay”. That means, in the long-run, you may bet on further growth – and further gains. At the same time, that doesn’t put away the necessity of technical analysis and being prepared to see corrections on the way – especially after these stunning leaps to the upside.

Finally, remember that you can trade stocks not only through MetaTrader 5 but FBS Trader, too!


                                                                                                  GO FOR IT


Apple event surprised traders
Apple event surprised traders

Every year in early autumn Apple holds its event where it presents new iPhones, Apple Watches, and iPads. This year wasn’t an exclusion. But yesterday’s presentation didn’t result in Apple stock growth, and here’s why.

Latest news

The US Dollar Is Correcting
The US Dollar Is Correcting

Inflation in Europe was released better than the forecast. The preliminary fact was published at 4.3%. What's happening in the markets?

Bearish Signal For The USD
Bearish Signal For The USD

XAUUSD fell below 1900 for the first time since March 2023. Meanwhile, the US dollar index gives a bearish signal. Read the full report to learn more!

Deposit with your local payment systems

Data collection notice

FBS maintains a record of your data to run this website. By pressing the “Accept” button, you agree to our Privacy policy.


A manager will call you shortly.

Change number

Your request is accepted.

A manager will call you shortly.

Next callback request for this phone number
will be available in

If you have an urgent issue please contact us via
Live chat

Internal error. Please try again later

Don’t waste your time – keep track of how NFP affects the US dollar and profit!

You are using an older version of your browser.

Update it to the latest version or try another one for a safer, more comfortable and productive trading experience.

Safari Chrome Firefox Opera